Decitabine for the treatment of acute myeloid leukaemia (terminated appraisal)

  • Technology appraisal
  • TA270
  • Published: 

History

Leukaemia (acute myeloid ) - decitabine: EIA form - scoping

Leukaemia (acute myeloid ) - decitabine: final scope

Leukaemia (acute myeloid ) - decitabine: final matrix

Leukaemia (acute myeloid ) - decitabine: response to consultee and commentator comments on the draft scope and provisional matrix

Acute myeloid leukaemia - decitabine: appendix B draft scope for consultation (pre-referral)

Acute myeloid leukaemia - decitabine: provisional matrix (pre-referral)